Vascular Solutions, Inc. (NASDAQ:VASC)

CAPS Rating: 5 out of 5

A medical device company focused on bringing clinically advanced solutions to interventional cardiologists and interventional radiologists worldwide.

Results 1 - 14 of 14

Recs

0
Member Avatar racoveanul (80.75) Submitted: 4/12/2014 3:33:34 PM : Outperform Start Price: $24.10 VASC Score: -1.82

My 1y target for Vascular Solutions (Symbol: VASC) is $ 25.8. It implies an increase of 8.51% of the share price (April 11 2014).

Recs

0
Member Avatar CMCassociates (68.03) Submitted: 11/7/2013 8:10:17 PM : Outperform Start Price: $19.62 VASC Score: +18.34

From the value investor's perspective, Vascular Solutions stands out as a reliably impressive performer considering its ROE, ROA, 5 year trailing earnings growth, and quick ratio. Specifically, I admire their STAGGERING 5-year earning growth rate compared to my other 8 premium medical device firms that I like. They also have a very healthy ROA relative to these other 8 peers. So I'm confident they'll be a great investment for the long haul.

Recs

0
Member Avatar MedtechInsider (< 20) Submitted: 9/13/2013 4:37:20 PM : Underperform Start Price: $16.69 VASC Score: -39.74

VSI may outperform in the short run, but (in my opinion) it will tank in the long run for the following reasons:

A large amount of its profits are from two devices, and the rest are from a multitude of small devices that do about $1 million in sales annually. This is bad for two reasons. The first is that those two devices could fail (in production, competition, ect) and then you're out a significant portion of the profits. The second is that VSI is wasting time and resources on these small products. VSI already outsources a significant portion of its manufacturing, and that cuts into the margins and outsourcing has cost the company with major recalls.

One of its flagship products, which accounts for VSI's rapid growth, now has a competing device made by BSX. Yes, VSI is suing BSX for patent infringement, but I foresee VSI losing this battle big time. VSI will then loose control of that segment, and from there the decent will be rapid.

While VSI does have some talented people, it has more blind leading the blind than it should, and its engineering staff is lacking in some very key areas. I've seen this first hand, and this should be a major concern.

For these reasons the stock is over valued, the company is overestimated in ability, and the investment base is being led down a bad path by CEO Howard Root. Only bad things can happen, and you should sell while you still can (in my opinion).

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/22/2013 5:22:16 PM : Outperform Start Price: $16.06 VASC Score: +41.04

Long. Medical instruments company. Nice steady growth. Buying back stock. Cash flow from operating activities growing. Earnings grew 17% on a 9% boost in revenues last quarter. Not bad here at 21x fwd estimates.

Recs

0
Member Avatar TerryHoodSr (65.20) Submitted: 7/29/2013 11:12:02 PM : Outperform Start Price: $19.96 VASC Score: +25.23

potential

Recs

1
Member Avatar chris293 (86.64) Submitted: 3/29/2012 7:03:51 PM : Outperform Start Price: $11.04 VASC Score: +95.93

by buying other companies and effectively digesting (using) them, vasc will be a better company.

Recs

2
Member Avatar valuefocusgroup (27.60) Submitted: 4/5/2011 9:47:32 AM : Outperform Start Price: $10.97 VASC Score: +89.00

Price/earnings of 8.72, market cap of 185.70 million, debt/equity of zero, Return on Invested Capital (TTM) of 40.91, based in Minnesota, United States, medical device company with focus on equipment for interventional cardiologists and interventional radiologists.

Recs

0
Member Avatar whomonkyoulus (28.55) Submitted: 2/24/2011 10:09:04 AM : Outperform Start Price: $11.00 VASC Score: +88.56

Long-term pick. They have a PE of 10 and good insider ownership.

Recs

2
Member Avatar AlphaCenturion (61.36) Submitted: 9/1/2010 12:36:41 AM : Outperform Start Price: $12.64 VASC Score: +18.29

Came across this stock while researching Abbot Labs. The rapid growth in vascular medicine shouldn't be surprising given the declining health of your average American over the last several years. I don't imagine this growth will slow any time soon and unlike your less invasive vascular treatments, medical devices aren't subject to threats from generic competition. The spread on VASC, however, is huge and being a microcap and all is probably too risky to buy in RL but the numbers certainly look good. As per usual, I'll be tracking this on CAPS for now and if the opportunity presents itself I may consider starting a position. The potential here is enormous.

Recs

1
Member Avatar stuinkc (48.99) Submitted: 10/22/2009 9:19:29 AM : Outperform Start Price: $8.56 VASC Score: +121.85

This stock is a hidden gem, going to buy and hold this one for 2-4 years+. Entry point in the 8 range and if it takes a dip to 6 i'm just going dca down and double my investment. Love the niche market, great growth rates, balance sheet and expanding product line. Micro cap status would prevent this vascular product line of even making a splash on an abt or jnj scale at this range, however, if growth continues this will be a buyout target at some point in time or worst case scenario be a market outperform.

Recs

0
Member Avatar MikeMotley (< 20) Submitted: 10/22/2009 9:10:16 AM : Outperform Start Price: $8.56 VASC Score: +121.85

spec pick

Recs

3
Member Avatar dwlivesay (< 20) Submitted: 5/29/2009 11:39:12 AM : Outperform Start Price: $7.32 VASC Score: +136.49

They have money. They don't owe money. They're making money. They make cutting edge medical products. Their webpage slogan is: unique solutions for unmet medical needs. That sounds like money. I'm on board. No, I don't work there and I'm not on the board of directors. just a company I found with some due dilligence.

Revenue growth chart is very juicy. I'm putting some coin in this one. Again, not a very sexy stock, but not every stock is POT, MOS, TC or AGR. I think you can wait on this one for a little while while you make money off fertilizer, but if you're looking to diversify, (and this coming from a guy who is in big with TC so take it for what is worth) I think this is a nice little medical play at a nice price. I think at some point people are going to take notice of this company and it'll either get bought or break out.

Recs

1
Member Avatar recifeboy (98.65) Submitted: 12/18/2008 3:02:56 PM : Outperform Start Price: $8.97 VASC Score: +62.13

This is a good company with carefull management that is doing well despite the current economic environment.The basic for the company are good and it is not very leveraged.

Recs

0
Member Avatar walakart (< 20) Submitted: 2/8/2007 3:36:50 PM : Outperform Start Price: $10.83 VASC Score: +95.93

latest rise

Results 1 - 14 of 14

Featured Broker Partners


Advertisement